🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/06/2019 | 80,78 | 81,10 | 79,40 | 80,31 | -0,56% | 2,10% | 822.800 |
| 11/06/2019 | 83,40 | 83,50 | 80,48 | 80,76 | -2,50% | 3,62% | 936.000 |
| 10/06/2019 | 81,78 | 83,90 | 81,36 | 82,83 | +1,04% | 3,11% | 741.700 |
| 07/06/2019 | 81,82 | 83,44 | 80,10 | 81,98 | +1,15% | 4,08% | 1.066.100 |
| 06/06/2019 | 82,83 | 83,82 | 80,94 | 81,05 | -2,34% | 3,48% | 1.014.500 |
| 05/06/2019 | 85,85 | 85,85 | 81,77 | 82,99 | -3,42% | 4,75% | 1.336.200 |
| 04/06/2019 | 83,52 | 86,83 | 83,06 | 85,93 | +2,62% | 4,51% | 1.265.500 |
| 03/06/2019 | 83,71 | 85,37 | 82,78 | 83,74 | -0,27% | 3,09% | 987.600 |
| 31/05/2019 | 85,94 | 85,94 | 83,51 | 83,97 | -3,20% | 2,83% | 1.073.200 |
| 30/05/2019 | 86,86 | 88,60 | 86,65 | 86,75 | -0,26% | 2,24% | 868.600 |
| 29/05/2019 | 86,33 | 87,34 | 85,34 | 86,98 | +0,42% | 2,32% | 820.300 |
| 28/05/2019 | 87,21 | 87,98 | 86,08 | 86,62 | -1,01% | 2,18% | 3.402.200 |
| 24/05/2019 | 85,98 | 88,80 | 85,80 | 87,50 | +1,76% | 3,49% | 900.800 |
| 23/05/2019 | 86,43 | 86,43 | 83,96 | 85,99 | -1,22% | 2,86% | 918.700 |
| 22/05/2019 | 88,91 | 89,74 | 85,94 | 87,05 | -1,92% | 4,27% | 568.900 |
| 21/05/2019 | 88,46 | 89,54 | 87,90 | 88,75 | +0,97% | 1,85% | 684.800 |
| 20/05/2019 | 90,03 | 90,57 | 87,76 | 87,90 | -3,03% | 3,12% | 726.300 |
| 17/05/2019 | 88,33 | 91,92 | 88,23 | 90,65 | +2,27% | 4,18% | 682.000 |
| 16/05/2019 | 89,18 | 89,96 | 88,26 | 88,64 | -0,77% | 1,91% | 891.800 |
| 15/05/2019 | 89,65 | 90,18 | 88,25 | 89,33 | -1,29% | 2,15% | 666.500 |
| 14/05/2019 | 90,28 | 91,91 | 89,57 | 90,50 | -0,26% | 2,59% | 830.300 |
| 13/05/2019 | 93,17 | 93,59 | 90,04 | 90,74 | -4,12% | 3,81% | 643.800 |
| 10/05/2019 | 96,00 | 96,00 | 93,27 | 94,64 | -2,11% | 2,84% | 688.400 |
| 09/05/2019 | 97,73 | 98,98 | 94,14 | 96,68 | +1,01% | 4,95% | 1.024.500 |
| 08/05/2019 | 99,14 | 100,20 | 95,60 | 95,71 | -3,80% | 4,64% | 829.800 |
| 07/05/2019 | 99,95 | 100,28 | 98,44 | 99,49 | -1,14% | 1,84% | 572.900 |
| 06/05/2019 | 97,75 | 100,96 | 97,51 | 100,64 | +2,03% | 3,53% | 532.100 |
| 03/05/2019 | 101,39 | 101,91 | 97,62 | 98,64 | -2,58% | 4,23% | 869.400 |
| 02/05/2019 | 100,10 | 101,47 | 99,38 | 101,25 | +1,96% | 2,09% | 692.900 |
| 01/05/2019 | 103,45 | 105,87 | 98,53 | 99,30 | -3,19% | 7,10% | 972.800 |